Individual lifestyle management: Manage the diet, exercise, weight and healthy lifestyle of pregnant women
Study summary
This study aims to explore whether early intervention for high-risk groups of gestational hyperglycemia can improve insulin resistance and effectively prevent the occurrence of GDM, and evaluate which pathophysiological subtypes of GDM have the best effect on improving maternal and fetal adverse prognosis, so as to provide evidence for stratified management and individualized clinical intervention of high glucose groups in pregnancy
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* 18-55 years old
* 6-14 weeks of pregnancy
* at least one risk factor for GDM
* signed a written informed consent
Exclusion Criteria:
* Individuals diagnosed with diabetes or prediabetes prior to pregnancy
* currently taking medications affecting blood glucose levels such as metformin
* women at risk of miscarriage
* individuals with chronic conditions (such as uncontrolled hypertension, severe heart disease)
* those with movement disorders or contraindicated conditions for physical activity
* patients undergoing gastrointestinal surgeries that alter glucose absorption
* those unable to maintain regular prenatal care (such as non-compliance with medical instructions or mental health issues).
Primary outcome measure(s)
The incidence of gestational diabetes(GDM) — 24-28 weeks pregnant The 75g 2h oral glucose tolerance test is performed at 24-28 weeks of gestation, and the cut-off points of venous blood glucose values are 5.1mmol/L (fasting), 10.0mmol/L (1h after glucose load), 8.5mmol/L (2h after glucose load). If any one of the three blood glucose measures is above the cut-off points, then GDM is diagnosed..
Trial sites (1)
Facility
City
Region
Status
Tianjin Central Hospital of Gynecology Obstetrics
Tianjin
China
More Tianjin Central Hospital of Gynecology Obstetrics trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.